[1] MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology,2013, 144(7):1426-1437. [2] YIN S, WANG S J, GU W Y, et al.Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients[J].J Dig Dis,2017, 18(5):292-301. [3] LI H,CHEN L Y,ZHANG N N, et al.Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B[J].Sci Rep,2016, 6:25487. [4] 中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南(2016年版)[J].中华临床感染病杂志,2016,9(2):97-103. [5] QIN G.Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure:a single-center experience[J].Medicine (Baltimore),2014, 93(28):e338. [6] REEVES H M, WINTERS J L.The mechanisms of action of plasma exchange[J].Br J Haematol,2014, 164:342-351. [7] KEKLIK M, SIVGIN S, KAYNAR L, et al.Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia:a single center experience[J].Transfus Apher Sci,2013, 48:323-326. [8] XU X,LIU X,LING Q, et al.Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure[J].PLoS One,2013, 8(3):e58738. [9] WAN Y M.Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-onchronic liver failure treated by entercavir:a prospective study[J].J Clin Apher,2017, 32:453-461. [10] YAO J,LI S,ZHOU L, et al.Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure[J].J Clin Apher,2019, 34(4):392-398. [11] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].实用肝脏病杂志,2013,16(3):210-216. [12] KATOONIZADEH A, LALEMAN W, VERSLYPE C, et al.Early features of acute-on-chronic alcoholic liver failure:a prospective cohort study[J].Gut,2010, 59(11):1561-1569. [13] RADHA KRISHNA Y,SARASWAT VA,DAS K, et al.Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis[J].Liver Int,2009, 29(3):392-398. [14] CORDOBA J,VENTURA-COTS M,SIMÓN-TALERO M, et al.Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)[J].J Hepatol,2014, 60(2):275-281. [15] JALAN R, GINES P, OLSON J C, et al.Acute-on chronic liver failure[J].J Hepatol, 2012, 57:1336-1348. [16] PICON R V.Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients[J].World J Gastroenterol,2017, 23(28):5237-5245. [17] WINTERS J L.Plasma exchange:concepts, mechanisms, and an overview of the American Society for Apheresis guidelines[J].Hematology Am Soc Hematol Educ Program,2012, 2012:7-12. [18] WINTERS J L.American Society for Apheresis guidelines on the use of apheresis in clinical practice:practical, concise, evidence-based recommendations for the apheresis practitioner[J].J Clin Apher,2014, 29(4):191-193. [19] LARSEN F S, SCHMIDT L E, BERNSMEIER C, et al.High-volume plasma exchange in patients with acute liver failure:an open randomised controlled trial[J].J Hepatol,2016, 64:69-78. [20] CHEN J J, HUANG J R, YANG Q, et al.Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure:a nationwide prospective multicenter study in China[J].Hepatobiliary Pancreat Dis Int,2016, 15:275-281. [21] WAN Y M.Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir:A prospective study[J].J Clin Apher,2017, 32(6):453-461.
2021, Vol. 38 
